Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-14

Clinical Trial Update: Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase 1/2 trial of X4P-001 in participants with advanced renal cell carcinoma have been posted. The study includes the clear cell renal cell carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • X4P-001

Snippet

Sponsor: X4 Pharmaceuticals | Conditions: Clear Cell Renal Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-08-14